Brandinium

Trademark search for:

FODOZAN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2007-03-14 — Application filed
  • 2007-03-19 — Application filed
  • 2007-06-25 — Assigned to examiner
  • 2007-06-26 — Approved for pub - principal register
  • 2007-08-10 — Assigned to lie
  • 2007-08-10 — Law office publication review completed
  • 2007-08-29 — Notice of publication
  • 2007-09-18 — Published for opposition
  • 2007-12-11 — Noa mailed - sou required from applicant
  • 2008-06-03 — Sou teas extension received
  • 2008-06-03 — Sou extension 1 filed
  • 2008-06-03 — Sou extension 1 granted
  • 2008-12-10 — Sou teas extension received
  • 2008-12-10 — Sou extension 2 filed
  • 2008-12-10 — Sou extension 2 granted
  • 2009-06-03 — Sou teas extension received
  • 2009-06-03 — Sou extension 3 filed
  • 2009-06-25 — Case assigned to intent to use paralegal
  • 2009-06-25 — Sou extension 3 granted
  • 2009-09-21 — Sou teas extension received
  • 2009-09-21 — Sou extension 4 filed
  • 2009-09-24 — Sou extension 4 granted
  • 2010-06-09 — Sou teas extension received
  • 2010-06-09 — Sou extension 5 filed
  • 2010-06-11 — Sou extension 5 granted
  • 2010-06-12 — Notice of approval of extension request e-mailed
  • 2010-12-11 — Use amendment filed
  • 2010-12-13 — Teas statement of use received
  • 2011-01-05 — Statement of use processing complete
  • 2011-01-27 — Final disposition recorded
  • 2011-01-27 — Final disposition recorded
  • 2011-01-27 — Final disposition recorded
  • 2011-07-29 — Paper received
  • 2011-08-08 — Assigned to lie
  • 2011-08-12 — Amendment from applicant entered
  • 2011-08-12 — Correspondence received in law office
  • 2011-08-31 — Office action issued
  • 2011-08-31 — Office action issued
  • 2011-08-31 — Office action issued
  • 2012-02-24 — Exparte appeal received at ttab
  • 2012-02-24 — Ex parte appeal-instituted
  • 2012-05-01 — Jurisdiction restored to examining attorney
  • 2012-06-20 — Su - examiner statement - written
  • 2012-06-20 — Notification of examiners statement e-mailed
  • 2012-06-20 — Examiners statement e-mailed
  • 2013-02-08 — Office action issued
  • 2013-04-26 — Application abandoned
  • 2013-04-26 — Application abandoned
  • 2013-04-26 — Exparte appeal terminated
  • 2013-04-26 — Final status recorded

Owner Information

BioCryst Pharmaceuticals, Inc.
Birmingham , AL
BioCryst Pharmaceuticals, Inc.
Birmingham , AL

Correspondent

NICHOLAS J LANDAU BRADLEY ARANT BOULT CUMMINGS LLP
ONE FEDERAL PLACE
1819 FIFTH AVENUE NORTH
BIRMINGHAM, AL 35203-2104

Filing Details

Filing Date:
2007-03-14
Status Date:
2013-04-26
Category:
Pharmaceuticals
Filing Year:
2007

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.